By Datamonitor Healthcare 18 October 2016
Regulatory pricing controls are being stepped up in countries where governments are subsidizing a growing share of overall drug costs, or have announced plans to do so. Generally, rates of change in pharmaceutical coverage determine the pace and exte... Read more
Page 1 of 50
You now have full access to all articles on our site for the next 28 days.